Token Price vs Mark Price: How OpenStocks Quotes Private Companies

Token Price vs Mark Price: How OpenStocks Quotes Private Companies

Understanding token price vs mark price OpenStocks uses on its trade desk is the fastest way to read the book without confusing on-chain quotes with round funding headlines. At app.openstocks.xyz/trade, every live product shows both a token price (with 30-day change and implied valuation) and a mark price (with premium/discount and mark valuation). Neither column claims to be equity fair value—OpenStocks sells economic price exposure via BEP-20 tokens, not ownership.

This article explains each field with the live 31 August 2026 figures for Anthropic, Figure AI, Anduril, and Neuralink, and why desk mark vals can differ from funding marks listed on product pages.

The columns that define the quote

On the Trade module you will see: Token price ("Live USDT-quoted price from PancakeSwap Infinity."), 30D % ("Change over the last 30 days."), Implied val (company valuation implied by the token price), Mark price + premium (reference mark and how token sits vs that mark), Mark val (company valuation implied by the mark), All-time vol (cumulative volume for the product), Address (on-chain contract for verification).

Premium is defined in the UI tooltip: "How much higher Token Price is versus Mark Price. +% = premium, −% = discount."

That single sentence is the operational definition. If token price equals mark price, premium is about 0%. If token trades below mark, premium is negative (a discount). If token trades above mark, premium is positive.

Live book: four worked examples

Anthropic (oANTHROPIC): token price $1,050.20 (+23.5% 30D), implied val $1.70T, mark price $1,056.00, premium −0.5% (slight discount), mark val $1.71T, all-time vol $12.53K, liq $1.16K, address 0x24B518b332543a4E1C3649d063daB199d103760a. Anthropic is the tightest token–mark pairing in the set. The product page also lists a Series H item dated 2026-05-28 ($65B at $965B), lower than the live desk's ~$1.70T / $1.71T implied and mark vals. OpenStocks does not "correct" one to the other.

Figure AI (oFIGUREAI): token $157.15 (−10.1% 30D) → implied $31.76B. Mark $165.45 → premium −5.0% → mark val $33.44B. All-time vol $12.55K, liq $187.28, address 0xF9D15fA2adF7942610E8A416363e037859F99E92. Token sits at a 5% discount to mark. The product page lists Series C 2025-09-16 ($1B at $39B)—a different reference layer than live mark val.

Anduril (oANDURIL): token $130.74 (+0.0% 30D) → implied $105.97B. Mark $138.14 → premium −5.4% → mark val $111.96B. All-time vol $12.38K, liq $303.81, address 0x5dcb20b5B75110B5F28387D8D3Bdd727a43310d5. The ticker strip also quotes Anduril at $138.14 (0.00% in the capture)—matching the desk mark. Product page lists Growth Equity 2026-07-24 at $100B, while desk mark val is about $111.96B.

Neuralink (oNEURALINK): token $250.19 (+0.0% 30D) → implied $48.77B. Mark $305.32 → premium −18.1% → mark val $59.52B. All-time vol $12.22K, liq $563.77, address 0xFb7F44e71D03adf619BeA2055437eC6453AB2552. Neuralink shows the widest discount in the live set. Liquidity on the row ($563.77) is the highest of the four, while Anthropic's liq ($1.16K) is the thinnest. Product page lists Series E 2025-05-27 ($656.5M at $9.6B), far below current desk mark val.

Why OpenStocks shows both (and why that helps)

Private-company price discovery is fragmented: funding rounds, secondary indications, and on-chain token markets rarely share one number. OpenStocks' design choice is transparency: token price is the live USDT-quoted price from PancakeSwap Infinity; mark price provides a parallel reference so premium/discount is visible; implied vs mark valuation scales those unit prices to company-level figures on the same row; addresses + BscScan let anyone verify the contract rather than trusting a screenshot.

Compared with opaque private-share chats that quote a single "last trade" without methodology, the dual quote is a real product fact you can inspect today on the trade desk—alongside AUM $6,560.84, volume $50.33K, 1,302 transactions, and 23 holders.

What premium is not

Not a guarantee of mean reversion. Not proof that mark or token is "right." Not equity NAV. Not investment advice.

Holding oANTHROPIC, oFIGUREAI, oANDURIL, or oNEURALINK still confers economic exposure only—no claim on the companies, no affiliation, no dividends or votes. Product pages repeat that disclaimer.

How to use the quote when deciding whether to open a flow

1. Note token price and 30D %.

2. Note mark and premium sign/magnitude.

3. Glance at liq and all-time vol (books are still small).

4. Open /products/ for company blurb and exposure disclaimer.

5. Verify address on BscScan via the Actions column.

6. Only then use Trade / Get ↗ for the off-site BSC trade flow.

7. Confirm holdings in Portfolio after connect (How it Works).

Also remember: Kalshi ($843.74) and Polymarket ($135.66) in the ticker are not dual-quoted trade rows here.

Related OpenStocks surfaces

Ecosystem — BNB Chain live; Allocations partnership live; other cards planned/soon. Audits — findings resolved; contracts source-verified on BscScan; PDF downloads Coming soon.

Related reading: Revolut IPO & Share Price: Can You Get Exposure?, Kraken IPO Date: Why It Paused and What Comes Next and How to Invest in Pre-IPO Companies 2026.

Bottom line on token price vs mark price

Token price vs mark price OpenStocks publishes is a dual-quote system: tradeable BEP-20 token level beside a reference mark, with explicit premium/discount and twin implied valuations. Live examples range from Anthropic's −0.5% to Neuralink's −18.1%. Funding marks on product pages may diverge from desk mark vals—that is expected. Read both layers; do not invent a third "corrected" valuation. Always refresh app.openstocks.xyz/trade for current numbers.

OpenStocks offer economic exposure to private companies only. No ownership, voting, or dividends. High-risk; possible total loss. No guaranteed secondary-market liquidity. Not affiliated with referenced companies. Not available in the US / to US persons. OpenStocks is not a broker-dealer, investment adviser, or exchange. Nothing here is investment advice.